Bolt Biotherapeutics, Inc.
BOLT
Last
$4.11
Day
+12.6%
1y
-38.3%
5y
-98.6%
52w
-49.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
3.62
EMA 50
3.74
EMA 200
4.54
20d high
-16.3%
5y high
-98.7%
5y range
0th
Positions held
Your positionsBOLT isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
2
Hold
watch
Signal
Neutral
Target
$4.08
Stop
$3.30
Stop distance
19.7%
Target vs last
-0.7%
Fundamentals
| Market cap | $7.03M | Enterprise value | $11.06M | Trailing P/E | — | Forward P/E | -0.18 |
| PEG | — | Price / book | 0.56 | Beta | 1.01 | Dividend yield | 0.00% |
| Revenue growth | -99.7% | Earnings growth | — | Gross margin | 0.0% | Operating margin | -1513.2% |
| Profit margin | 0.0% | ROE | -111.6% | ROA | -30.7% | Debt / equity | 1.71 |
| Current ratio | 2.61 | Free cash flow | -$18.79M | Analyst recommendation | none | Mean target | $29.00 |
| 52w high | $7.20 | 52w low | $3.10 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $2.5M | $2.2M | $1.8M |
| Op margin | -151320.0% | -29234.6% | -224.2% | -355.1% | -510.5% |
| Net income | -$7.7M | -$7.2M | -$6.6M | -$7.1M | -$8.6M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$7.6M | -$7.6M | -$5.6M | -$7.7M | -$9.2M |
- Revenue -81% vs prior quarter ($0.0M vs $0.0M).
- Operating margin compressed to -151320%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $7.7M | $7.7M | $7.9M | $5.7M | — |
| Op margin | -450.1% | -887.3% | -967.4% | -1576.6% | — |
| Net income | -$33.4M | -$63.1M | -$69.2M | -$88.1M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$34.6M | -$68.2M | -$76.2M | -$90.3M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsBOLT · daily+1.7% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin